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SUMOylation of Neuronal
The rate of sudden death in patients with epilepsy is over 20 times higher than in the general population (Shorvon and Tomson, 2011) . Sudden unexpected death in epilepsy, or SUDEP, is the primary cause of mortality in patients with epileptic disorders. Although SUDEP is clearly linked to mutations in ion channels (Auerbach et al., 2013; Glasscock et al., 2010; Goldman et al., 2009; Kalume et al., 2013; Massey et al., 2014; Surges and Sander, 2012) , the specific underlying pathophysiological mechanism(s) remains elusive, and biomarkers are not currently available. Thus, SUDEP represents a major unmet clinical need and a current focus of intense investigation. Animal model and clinical studies show that, in addition to neuronal synchrony and hyperexcitability, respiratory and cardiovascular abnormalities during and after seizures contribute to SUDEP, suggesting important interactions between brain and heart. In this issue of Neuron, Qi et al. (2014) give new perspective to the growing list of potential SUDEP mechanisms, proposing that genes within the ion channel protein interactome may be pathogenic candidates.
Looking beyond mutations in ion channels themselves, Qi and colleagues (Qi et al., 2014) examine the in vivo role of the dynamic processes of SUMOylation on neuronal excitability and its relationship to SUDEP and seizures. SUMOylation, the addition of ubiquitin-like SUMO-modifying groups to lysine residues, and subsequent de-SUMOylation by Sentrin/SUMO-specific protease (SENPs), is known to alter protein function and localization in multiple tissues, including brain and heart (Droescher et al., 2013; Wang, 2011 Levin and Meisler, 2004) , the neomycin cassette interfered with SENP2 expression, resulting in a hypomorphic allele.
Because SENP2 protein is responsible for de-SUMOylation, the authors of this study proposed that SENP2 deficiency may result in increased levels of SUMOylation. Consistent with this, SUMO-1-and SUMO-2/3-conjugated proteins were found to accumulate in brain and heart in SENP fxN/fxN mice.
Real-time PCR analysis showed that SUMO-1 and SUMO-2/3 mRNA levels were similar between genotypes, (Kalume et al., 2013) , neuronal-specific, but not cardiac-specific, deletion of SENP2 recapitulated the global hypomorphic phenotype, suggesting that the change in neuronal excitability with hyperSUMOylation of K+ channels is responsible for the SUDEP.
The cardiac abnormalities in the Scn1a +/À model of Dravet are due to postseizure increase in parasympathetic tone (Kalume et al., 2013) . Seizures in SENP2 fxN/fxN mice were reliably induced with auditory stimulation and were used by the authors to follow and characterize whether seizures in these animals were also due to parasympathetic tone. Indeed, Qi and colleagues (Qi et al., 2014) found that seizures were followed by sinus pauses or AV conduction block, which could be prevented by pretreatment of the animals with atropine, but not propranolol. Finally, to test whether the SENP2 deficiency-induced reduction of M-current is responsible for neuronal hyperexcitability and SUDEP in (Qi et al., 2014 ) present a comprehensive and compelling study demonstrating that SENP2 deficiency, resulting in hyperSUMOylation of Kv7channels, causes the development of spontaneous seizures, cardiac abnormalities, and SUDEP in mice. This impressive body of work identifies a new animal model of SUDEP, presents the first in vivo evidence for a functional role of SUMOylation on ion channel activity, and demonstrates that hyper-SUMOylation of ion channel proteins is an important molecular mechanism and potential pathway for development of novel epilepsy therapeutics. These findings in mouse models suggest that it may be informative to screen for genetic variations in SENP genes in patients with epilepsy. In addition to components of the SUMO pathway, this important work suggests that pharmacological modulation of M-channel activity may be useful in preventing SUDEP in human patients.
SUMOylation is important not only for K + channel modulation but also for modulation of other major participants in neuronal excitability, at least in vitro. Thus, the underlying mechanism of hyperexcitability and SUDEP in this mouse model may involve additional players. For example, SUMO has been shown to modulate other ion channels, neurotransmitter receptors, scaffolding proteins, axon guidance molecules, and proteins involved in synaptic function and neurotransmitter release (Luo et al., 2013; Wilkinson et al., 2010) . In the Qi et al. study (Qi et al., 2014) , enhancement of M-currents via application of the M-channel opener retigabine effectively suppressed neuronal hyperexcitability and prevented the development of seizures and abnormal cardiac activity. Though compelling, this result is not definitive evidence that hyper-SUMOylation of channels that express M-current is the only underlying defect in this mouse model. It is well known that increasing M-channel activity stabilizes the membrane potential and effectively suppresses neuronal excitability regardless of the primary insult. Thus, in future studies it will be important to explore other potential players in the mechanism underlying SENP2 deficiency-induced hyperexcitability and SUDEP. Another interesting future direction of this work is to understand the neuronal subtypes involved in this mechanism. Here, Qi et al. (2014) examined membrane excitability and firing patterns in CA3 pyramidal cells. However, M-currents are also expressed in hippocampal GABAergic interneurons (Grigorov et al., 2014) . Are these neurons also affected by SENP2 deficiency-induced hyper-SUMOylation? If so, the plot of this story will thicken. Nevertheless, this important and timely work opens new avenues toward a cure for epilepsy and SUDEP prevention.
